Maastricht Radiation Oncology Clinic

MAASTRO clinic has a strategic agreement with the GROW research institute, the Faculty of Health Medicine and Life Sciences at Maastricht University and the University Hospital of Maastricht. Their aim is to develop a patient database of all the known and potentially predictive factors that are associated with the prognosis of cancer. The profiles that can then be determined provide a basis for identifying subgroups or individuals for whom specific treatments are most suitable, with the least chance of side effects.

Three of the strategic highlights of MAASTRO are: Lung Cancer, Tumour Hypoxia and Molecular Imaging. MAASTRO Clinic offers state-of-the-art radiotherapy to more than 3500 cancer patients each year from the Mid and South Limburg area in the Netherlands.

Role

MAASTRO will participate to the development of the EURECA interoperability environment and in the implementation and validation of several EURECA scenarios (e.g. patient recruitment, trial execution, etc.). We will contribute data and clinical knowledge and link the EURECA project to the large regional euroCAT and duCAT projects. Our aim in EURECA is to also develop a patient database of all the known and potentially predictive factors that are associated with the prognosis of cancer. The profiles that can then be determined provide a basis for identifying subgroups or individuals for whom specific treatments are most suitable, with the least chance of side effects. This should lead to a Decision Support System. Three of the strategic highlights of MAASTRO are: Lung Cancer, Tumour Hypoxia and Molecular Imaging.

Website

http://www.maastro.nl